{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:10:55Z","timestamp":1794431455386,"version":"4.9.1"},"reference-count":207,"publisher":"Oxford University Press (OUP)","issue":"31","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"publisher","award":["2020B008"],"award-info":[{"award-number":["2020B008"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERA4Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although prompt primary percutaneous coronary intervention (PCI) reduces mortality in patients with ST-elevation myocardial infarction (STEMI), the burden of post-infarction heart failure remains considerable and is expected to increase. A major contributory factor is suboptimal myocardial reperfusion, which persists in up to 60% of cases even with timely revascularization. This is largely driven by microvascular obstruction and ischaemia\u2013reperfusion injury, culminating in the no-reflow phenomenon, a critical prognostic factor associated with impaired infarct healing, adverse left ventricular remodelling, and increased risk of heart failure and death. No-reflow is a complex and heterogeneous phenomenon, identifiable through different invasive and noninvasive technologies. When observed post-PCI, after excluding residual epicardial stenosis, it indicates poor microvascular perfusion and necessitates urgent management. Identifying patients at high risk and implementing early targeted interventions are essential to improving outcomes. Pharmacological therapies, including intracoronary adenosine and nitroprusside, have shown unclear benefit in improving microvascular flow. Non-pharmacological strategies, such as ischaemic postconditioning, intracoronary supersaturated oxygen therapy, stent-retriever thrombectomy, and mechanical left ventricular unloading, have demonstrated promise but require further validation in large-scale clinical trials. This clinical consensus statement summarizes current strategies for the prevention and treatment of no-reflow and underscores the need for improved risk stratification and novel microvasculature-targeted therapies. Addressing this persistent and significant unmet clinical need is crucial for improving care for STEMI patients and for mitigating its long-term complications, including heart failure and mortality.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag334","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:53:59Z","timestamp":1776430439000},"page":"4215-4241","source":"Crossref","is-referenced-by-count":8,"title":["Pathophysiology, prevention, and management of coronary microvascular obstruction"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-3324","authenticated-orcid":false,"given":"Edina","family":"Cenko","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna , Via Giuseppe Massarenti 9, Bologna 40138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-2459","authenticated-orcid":false,"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[{"name":"Universitat de Vic\u2014UCC School of Medicine and Iris-CC , Barcelona ,","place":["Spain"]},{"name":"CiberCV, Institute Carlos III , Madrid ,","place":["Spain"]},{"name":"Cardiovascular Research Foundation for Health and Innovation (FICSI) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0869-4855","authenticated-orcid":false,"given":"Giuseppe","family":"Vadal\u00e0","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospital Paolo Giaccone , Palermo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-831X","authenticated-orcid":false,"given":"Daphne","family":"Merkus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]},{"name":"Walter Brendel Center of Experimental Medicine, University Clinic Munich, LMU Munich Institute of Surgical Research, , Munich ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Munich Heart Alliance (MHA), Partner Site Munich , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-5423","authenticated-orcid":false,"given":"Charalambos","family":"Antoniades","sequence":"additional","affiliation":[{"name":"Acute Multidisciplinary Imaging and Interventional Centre, RDM Division of Cardiovascular Medicine, University of Oxford , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-0082","authenticated-orcid":false,"given":"Carlos","family":"Collet","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, AZORG , Aalst ,","place":["Belgium"]},{"name":"Clinical Trial Center, Cardiovascular Research Foundation , NewYork, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3572-1855","authenticated-orcid":false,"given":"Giovanni Luigi","family":"De Maria","sequence":"additional","affiliation":[{"name":"Acute Multidisciplinary Imaging and Interventional Centre, RDM Division of Cardiovascular Medicine, University of Oxford , Oxford ,","place":["UK"]},{"name":"Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust , Oxford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2359-5192","authenticated-orcid":false,"given":"Ana","family":"Djordjevic-Dikic","sequence":"additional","affiliation":[{"name":"Medical Faculty, Cardiology Clinic, University Clinical Center, University of Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4964-7721","authenticated-orcid":false,"given":"Ines","family":"Drenjancevic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Osijek, Dept of Physiology and Immunology, Osijek and Scientific Centre of Excellence for Personalized Health Care University of Osijek , Osijek ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-0112","authenticated-orcid":false,"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos and Complutense University of Madrid , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-9575","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Ferreiro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitari Joan XXIII-Institut de Recerca Biom\u00e8dica Catalunya Sud, CIBER-CV, Tarragona, Spain and Rovira i Virgili University, Tarragona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-3635","authenticated-orcid":false,"given":"Ingrid","family":"Fleming","sequence":"additional","affiliation":[{"name":"Institute for Vascular Signalling, Centre of Molecular Medicine, Goethe University , Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-7849","authenticated-orcid":false,"given":"Tomasz","family":"Guzik","sequence":"additional","affiliation":[{"name":"Centre of Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh ,","place":["UK"]},{"name":"Department of Internal Medicine, 5th Military Hospital, Jagiellonian University Collegium Medicum , Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-2401","authenticated-orcid":false,"given":"Olivia","family":"Manfrini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna , Via Giuseppe Massarenti 9, Bologna 40138 ,","place":["Italy"]},{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola Hospital , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-1570","authenticated-orcid":false,"given":"Davor","family":"Milicic","sequence":"additional","affiliation":[{"name":"University of Zagreb, School of Medicine; Department of Cardiovascular Diseases, University Hospital Center Zagreb , Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-954X","authenticated-orcid":false,"given":"Teresa","family":"Padro","sequence":"additional","affiliation":[{"name":"CiberCV, Institute Carlos III , Madrid ,","place":["Spain"]},{"name":"Sant Pau Research Institute (IR SANT PAU) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-5046","authenticated-orcid":false,"given":"Italo","family":"Porto","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino Cardiovascular Disease Unit, , Genoa ,","place":["Italy"]},{"name":"University of Genoa Department of Internal Medicine and Medical Specialties, , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-4680","authenticated-orcid":false,"given":"Laurent Marc","family":"Riou","sequence":"additional","affiliation":[{"name":"Laboratoire Radiopharmaceutiques Biocliniques, UMR Univ. Grenoble Alpes\u2014INSERM 1039 , Grenoble ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-8790","authenticated-orcid":false,"given":"Nicola","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aberdeen Royal Infirmary , Aberdeen","place":["UK"]},{"name":"University of Aberdeen , Aberdeen ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7492-4984","authenticated-orcid":false,"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2930-1152","authenticated-orcid":false,"given":"Heleen M M","family":"van Beusekom","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-6691","authenticated-orcid":false,"given":"Marija","family":"Vavlukis","sequence":"additional","affiliation":[{"name":"University Clinic for Cardiology , Skopje, Republic of North Macedonia"},{"name":"Faculty of Medicine, Ss. Cyril and Methodius University in Skopje , Skopje , Republic of North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-8873","authenticated-orcid":false,"given":"Gemma","family":"Vilahur","sequence":"additional","affiliation":[{"name":"CiberCV, Institute Carlos III , Madrid ,","place":["Spain"]},{"name":"Sant Pau Research Institute (IR SANT PAU) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-0263","authenticated-orcid":false,"given":"Marija","family":"Zdravkovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Clinical Hospital Center Bezanijska Kosa , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-2241","authenticated-orcid":false,"given":"Dirk J","family":"Duncker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-2251","authenticated-orcid":false,"given":"Alfredo Ruggero","family":"Galassi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo , Palermo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-6818","authenticated-orcid":false,"given":"Raffaele","family":"Bugiardini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna , Via Giuseppe Massarenti 9, Bologna 40138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"2026103012565209100_ehag334-B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/01.res.19.1.57","article-title":"Blood supply of the myocardium after temporary coronary occlusion","volume":"19","author":"Krug","year":"1966","journal-title":"Circ Res"},{"key":"2026103012565209100_ehag334-B2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"J Clin Invest"},{"key":"2026103012565209100_ehag334-B3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/s0735-1097(85)80381-8","article-title":"Scintigraphic evidence of the \u201cno reflow\u201d phenomenon in human beings after coronary thrombolysis","volume":"5","author":"Schofer","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B4","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1161\/01.cir.93.11.1993","article-title":"Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1053\/euhj.2000.2172","article-title":"The coronary no-reflow phenomenon: a review of mechanisms and therapies","volume":"22","author":"Eeckhout","year":"2001","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B6","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ijcard.2016.07.209","article-title":"The no-reflow phenomenon in the young and in the elderly","volume":"222","author":"Cenko","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026103012565209100_ehag334-B8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.amjcard.2012.09.015","article-title":"Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction","volume":"111","author":"Harrison","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings","volume":"312","author":"TIMI Study Group","year":"1985","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0002-8703(99)70380-7","article-title":"Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI study group","volume":"137","author":"Gibson","year":"1999","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/01.CIR.101.2.125","article-title":"Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs","volume":"101","author":"Gibson","year":"2000","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2004.02.031","article-title":"Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion","volume":"93","author":"Giugliano","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026103012565209100_ehag334-B15","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/jcm12175592","article-title":"Coronary no-reflow after primary percutaneous coronary intervention-current knowledge on pathophysiology, diagnosis, clinical impact and therapy","volume":"12","author":"Ndrepepa","year":"2023","journal-title":"J Clin Med"},{"key":"2026103012565209100_ehag334-B16","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2009.07.042","article-title":"Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology","volume":"54","author":"Schwartz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jcin.2008.03.015","article-title":"Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: quantitative study with Doppler guidewire","volume":"1","author":"Okamura","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.293.9.1063","article-title":"Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial","volume":"293","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"2026103012565209100_ehag334-B19","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehad088","article-title":"Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction","volume":"44","author":"Lee","year":"2023","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41569-021-00632-2","article-title":"A fresh look at coronary microembolization","volume":"19","author":"Kleinbongard","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026103012565209100_ehag334-B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3909\/ricm0699","article-title":"Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation","volume":"15","author":"Feher","year":"2014","journal-title":"Rev Cardiovasc Med"},{"key":"2026103012565209100_ehag334-B22","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.107.704155","article-title":"Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation","volume":"116","author":"Antoniades","year":"2007","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00395-015-0508-3","article-title":"Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow","volume":"110","author":"Uitterdijk","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"2026103012565209100_ehag334-B24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/FJC.0000000000001317","article-title":"Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial (PodCAST-PCI)","volume":"80","author":"Hosseini","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026103012565209100_ehag334-B25","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.2174\/1381612824666180911122230","article-title":"Coronary microcirculation and the no-reflow phenomenon","volume":"24","author":"Oikonomou","year":"2018","journal-title":"Curr Pharm Des"},{"key":"2026103012565209100_ehag334-B26","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/eurheartj\/ehl119","article-title":"Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization","volume":"27","author":"Niccoli","year":"2006","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ahj.2010.02.019","article-title":"Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging","volume":"159","author":"Eitel","year":"2010","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/01.cir.91.5.1457","article-title":"Angiotensin II. Adrenergic sympathetic constrictor action in humans","volume":"91","author":"Lyons","year":"1995","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.235713","article-title":"Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation","volume":"108","author":"Kleinbongard","year":"2011","journal-title":"Circ Res"},{"key":"2026103012565209100_ehag334-B30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s0002-8703(99)70410-2","article-title":"Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction","volume":"137","author":"Fallen","year":"1999","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1056\/NEJM199704243361703","article-title":"Effects of cardiac sympathetic innervation on coronary blood flow","volume":"336","author":"Di Carli","year":"1997","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00395-006-0615-2","article-title":"The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion","volume":"101","author":"Reffelmann","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"2026103012565209100_ehag334-B33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/01.cir.62.5.945","article-title":"Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?","volume":"62","author":"Kloner","year":"1980","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B34","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/01.cir.62.6.1274","article-title":"The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion","volume":"62","author":"Fishbein","year":"1980","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B35","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/01.cir.89.6.2562","article-title":"Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography","volume":"89","author":"Ragosta","year":"1994","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijcard.2017.01.079","article-title":"Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia\/reperfusion model","volume":"236","author":"Dai","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026103012565209100_ehag334-B37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrcardio.2017.102","article-title":"New and revisited approaches to preserving the reperfused myocardium","volume":"14","author":"Kloner","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026103012565209100_ehag334-B38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jcmg.2023.01.017","article-title":"Angiography-derived and sensor-wire methods to assess coronary microvascular dysfunction in patients with acute myocardial infarction","volume":"16","author":"Scarsini","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B39","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/heartjnl-2017-311431","article-title":"Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction","volume":"104","author":"de Waard","year":"2018","journal-title":"Heart"},{"key":"2026103012565209100_ehag334-B41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ehj.2003.11.009","article-title":"Validation of coronary flow reserve measurements by thermodilution in clinical practice","volume":"25","author":"Barbato","year":"2004","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B42","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.jcmg.2021.02.023","article-title":"Coronary microvascular dysfunction assessed by pressure wire and CMR after STEMI predicts long-term outcomes","volume":"14","author":"Scarsini","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B43","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jcin.2023.08.030","article-title":"The index of microcirculatory resistance after primary PCI: a pooled analysis of individual patient data","volume":"16","author":"El Farissi","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B44","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehv353","article-title":"How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?","volume":"36","author":"De Maria","year":"2015","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B45","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.4244\/EIJ-D-18-00378","article-title":"Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction\u2014Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study)","volume":"14","author":"De Maria","year":"2018","journal-title":"EuroIntervention"},{"key":"2026103012565209100_ehag334-B46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005409","article-title":"Index of microcirculatory resistance at the time of primary percutaneous coronary intervention predicts early cardiac complications: insights from the OxAMI (Oxford Study in Acute Myocardial Infarction) cohort","volume":"6","author":"Fahrni","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026103012565209100_ehag334-B47","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.jcin.2023.09.027","article-title":"Continuous vs bolus thermodilution to assess microvascular resistance reserve","volume":"16","author":"Gallinoro","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B48","doi-asserted-by":"publisher","first-page":"132256","DOI":"10.1016\/j.ijcard.2024.132256","article-title":"Angiography-versus wire-based microvascular resistance index to detect coronary microvascular obstruction associated with ST-segment elevation myocardial infarction","volume":"411","author":"Wang","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026103012565209100_ehag334-B49","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2021.08.017","article-title":"Microvascular resistance reserve for assessment of coronary microvascular function: JACC technology corner","volume":"78","author":"De Bruyne","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B50","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacc.2024.05.004","article-title":"The influence of epicardial resistance on microvascular resistance reserve","volume":"84","author":"Mahendiran","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jacc.2023.12.014","article-title":"Measuring absolute coronary flow and microvascular resistance by thermodilution: JACC review topic of the week","volume":"83","author":"Belmonte","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B52","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jacc.2024.02.052","article-title":"Prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction","volume":"83","author":"Eerdekens","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amjcard.2006.01.097","article-title":"Sources of error and interpretation of plaque morphology by optical coherence tomography","volume":"98","author":"Manfrini","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B54","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcin.2017.01.044","article-title":"Impact of plaque rupture detected by optical coherence tomography on transmural extent of infarction after successful stenting in ST-segment elevation acute myocardial infarction","volume":"10","author":"Satogami","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","article-title":"Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction","volume":"21","author":"Galli","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026103012565209100_ehag334-B56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/circinterventions.111.965624","article-title":"Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography","volume":"5","author":"Porto","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ehjci\/jev341","article-title":"Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture","volume":"18","author":"Soeda","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B58","doi-asserted-by":"publisher","first-page":"101893","DOI":"10.1016\/j.jacadv.2025.101893","article-title":"Stent-retriever thrombectomy in STEMI with large thrombus burden: the RETRIEVE AMI randomized trial","volume":"4","author":"Kotronias","year":"2025","journal-title":"JACC Adv"},{"key":"2026103012565209100_ehag334-B59","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/circulationaha.105.593210","article-title":"Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound","volume":"114","author":"Porto","year":"2006","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B60","doi-asserted-by":"publisher","first-page":"100953","DOI":"10.1016\/j.ijcha.2022.100953","article-title":"No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction","volume":"38","author":"Katayama","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026103012565209100_ehag334-B61","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B62","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B63","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/01.CIR.0000147778.05979.E6","article-title":"Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction","volume":"110","author":"Schroder","year":"2004","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B64","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.123.064521","article-title":"STREAM-2: half-dose tenecteplase or primary percutaneous coronary intervention in older patients with ST-segment-elevation myocardial infarction: a randomized, open-label trial","volume":"148","author":"Van de Werf","year":"2023","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ahj.2023.12.009","article-title":"The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI\u2014a substudy of the randomized TOTAL trial","volume":"269","author":"Siren","year":"2024","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B66","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jacc.2007.08.062","article-title":"Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction","volume":"51","author":"Fearon","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0002-9149(99)00736-5","article-title":"ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators","volume":"85","author":"de Lemos","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B68","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011190","article-title":"Sex-specific treatment effects after primary percutaneous intervention: a study on coronary blood flow and delay to hospital presentation","volume":"8","author":"Cenko","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026103012565209100_ehag334-B69","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jacc.2004.11.044","article-title":"The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation","volume":"45","author":"Vogel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00395-006-0618-z","article-title":"Evaluating the \u2018no reflow\u2019 phenomenon with myocardial contrast echocardiography","volume":"101","author":"Kaul","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"2026103012565209100_ehag334-B71","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jacc.2007.03.036","article-title":"Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction","volume":"50","author":"Dwivedi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B72","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.jacc.2008.01.064","article-title":"Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction","volume":"51","author":"Hirsch","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B73","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.echo.2005.09.021","article-title":"Coronary flow velocity pattern assessed noninvasively by transthoracic color Doppler echocardiography serves as a predictor of adverse cardiac events and left ventricular remodeling in patients with acute myocardial infarction","volume":"19","author":"Katayama","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"2026103012565209100_ehag334-B74","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.ultrasmedbio.2024.06.001","article-title":"A shape-consistent deep-learning segmentation architecture for low-quality and high-interference myocardial contrast echocardiography","volume":"50","author":"Cui","year":"2024","journal-title":"Ultrasound Med Biol"},{"key":"2026103012565209100_ehag334-B75","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/s0735-1097(98)00435-5","article-title":"Assessment of \u201cmicrovascular no-reflow phenomenon\u201d using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction","volume":"32","author":"Kondo","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B76","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s002590050378","article-title":"Early detection of the no-reflow phenomenon in reperfused acute myocardial infarction using technetium-99m tetrofosmin imaging","volume":"26","author":"Hamada","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"2026103012565209100_ehag334-B77","first-page":"363","article-title":"Detecting myocardial salvage after primary PTCA: early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging","volume":"40","author":"Sciagra","year":"1999","journal-title":"J Nucl Med"},{"key":"2026103012565209100_ehag334-B78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1161\/CIRCIMAGING.108.846253","article-title":"Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography\/computed tomography: evaluation in a porcine model of myocardial infarction","volume":"2","author":"Lautamaki","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","article-title":"Coronary microvascular obstruction: the new frontier in cardioprotection","volume":"114","author":"Heusch","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"2026103012565209100_ehag334-B80","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"van Kranenburg","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B81","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","article-title":"Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis","volume":"7","author":"Hamirani","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B82","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jcmg.2017.05.023","article-title":"Long-term incremental prognostic value of cardiovascular magnetic resonance after ST-segment elevation myocardial infarction: a study of the collaborative registry on CMR in STEMI","volume":"11","author":"Symons","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B83","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jacc.2024.03.408","article-title":"Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI","volume":"83","author":"Lechner","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B84","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcmg.2017.01.008","article-title":"Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials","volume":"10","author":"Bulluck","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B86","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.116.025582","article-title":"Dynamic edematous response of the human heart to myocardial infarction: implications for assessing myocardial area at risk and salvage","volume":"136","author":"Fernandez-Jimenez","year":"2017","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.123.015490","article-title":"Perfect match: radiomics and artificial intelligence in cardiac imaging","volume":"17","author":"Baessler","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B88","doi-asserted-by":"publisher","first-page":"1274267","DOI":"10.3389\/fcvm.2023.1274267","article-title":"Non-contrast cine cardiovascular magnetic resonance-based radiomics nomogram for predicting microvascular obstruction after reperfusion in ST-segment elevation myocardial infarction","volume":"10","author":"Liu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026103012565209100_ehag334-B89","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jcmg.2025.08.016","article-title":"Evaluating acute ischemic myocardial injury with photon-counting computed tomography","volume":"19","author":"Kotronias","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B90","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2025.07.022","article-title":"Photon-counting computed tomography in cardiac imaging","volume":"19","author":"Shiyovich","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B91","doi-asserted-by":"publisher","DOI":"10.1093\/radadv\/umaf023","article-title":"Deep learning pipeline for fully automated myocardial infarct segmentation from clinical cardiac MR scans","volume":"2","author":"Schwab","year":"2025","journal-title":"Radiol Adv"},{"key":"2026103012565209100_ehag334-B92","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.125.016104","article-title":"Association between artificial intelligence detected features on the ECG and presence of microvascular obstruction","volume":"19","author":"Traverse","year":"2026","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B93","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjcard.2006.08.054","article-title":"Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality","volume":"99","author":"Brosh","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B94","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1161\/CIRCULATIONAHA.108.799981","article-title":"Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction","volume":"119","author":"Chan","year":"2009","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B95","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.CIR.0000118496.44135.A7","article-title":"Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction","volume":"109","author":"Bolognese","year":"2004","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B96","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B97","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.amjcard.2003.08.056","article-title":"Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction","volume":"92","author":"Mehta","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B98","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4244\/EIJ-D-17-00269","article-title":"Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry","volume":"14","author":"Papapostolou","year":"2018","journal-title":"EuroIntervention"},{"key":"2026103012565209100_ehag334-B99","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.2174\/1381612824666180702112536","article-title":"Coronary no-reflow phenomenon in clinical practice","volume":"24","author":"Scarpone","year":"2018","journal-title":"Curr Pharm Des"},{"key":"2026103012565209100_ehag334-B100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.123.013738","article-title":"No-reflow prediction in acute coronary syndrome during percutaneous coronary intervention: the NORPACS risk score","volume":"17","author":"Dawson","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B101","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1093\/eurheartj\/ehaf1059","article-title":"Sex and gender differences in coronary pathophysiology and ischaemic heart disease","volume":"47","author":"Manfrini","year":"2026","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B102","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ehj.2004.03.021","article-title":"Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty","volume":"25","author":"De Luca","year":"2004","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B103","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.amjcard.2011.07.010","article-title":"Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction","volume":"108","author":"Fokkema","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B104","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jcin.2015.08.031","article-title":"Effect of ischemia duration and door-to-balloon time on myocardial perfusion in ST-segment elevation myocardial infarction: an analysis from HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)","volume":"8","author":"Prasad","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B105","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009879","article-title":"Time delay, infarct size, and microvascular obstruction after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction","volume":"14","author":"Redfors","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B106","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2022.03.354","article-title":"Reduced heart failure and mortality in patients receiving statin therapy before initial acute coronary syndrome","volume":"79","author":"Bugiardini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B107","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","author":"Kim","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B108","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.amjcard.2004.02.037","article-title":"Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty","volume":"93","author":"Manfrini","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B109","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.2018.2444","article-title":"Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trial","volume":"319","author":"Berwanger","year":"2018","journal-title":"JAMA"},{"key":"2026103012565209100_ehag334-B110","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jamacardio.2018.3408","article-title":"Timing of loading dose of atorvastatin in patients undergoing percutaneous coronary intervention for acute coronary syndromes: insights from the SECURE-PCI randomized clinical trial","volume":"3","author":"Lopes","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026103012565209100_ehag334-B111","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jama.2020.0118","article-title":"Major adverse cardiovascular events after 12 months among patients with acute coronary syndrome receiving loading doses of atorvastatin prior to planned PCI","volume":"323","author":"Lopes","year":"2020","journal-title":"JAMA"},{"key":"2026103012565209100_ehag334-B112","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cvr\/cvae264","article-title":"Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction","volume":"121","author":"Vilahur","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026103012565209100_ehag334-B113","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jacc.2019.05.020","article-title":"Intravenous statin administration during ischemia exerts cardioprotective effects","volume":"74","author":"Mendieta","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B114","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jacc.2020.01.042","article-title":"Intravenous statin administration during myocardial infarction compared with oral post-infarct administration","volume":"75","author":"Mendieta","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B115","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","article-title":"Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation","volume":"41","author":"Clemente-Moragon","year":"2020","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B116","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","article-title":"Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B117","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of metoprolol in cardioprotection during an acute myocardial infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B118","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B119","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12872-021-02301-1","article-title":"Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Geng","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026103012565209100_ehag334-B120","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028623","article-title":"Canagliflozin improves myocardial perfusion, fibrosis, and function in a swine model of chronic myocardial ischemia","volume":"12","author":"Sabe","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026103012565209100_ehag334-B121","doi-asserted-by":"publisher","first-page":"8986","DOI":"10.1038\/s41598-025-93483-7","article-title":"Empagliflozin demonstrates neuroprotective and cardioprotective effects by reducing ischemia\/reperfusion damage in rat models of ischemic stroke and myocardial infarction","volume":"15","author":"Dai","year":"2025","journal-title":"Sci Rep"},{"key":"2026103012565209100_ehag334-B122","doi-asserted-by":"publisher","first-page":"165770","DOI":"10.1016\/j.bbadis.2020.165770","article-title":"SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models","volume":"1866","author":"Andreadou","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2026103012565209100_ehag334-B123","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.2337\/dc12-2469","article-title":"Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes","volume":"36","author":"Ceriello","year":"2013","journal-title":"Diabetes Care"},{"key":"2026103012565209100_ehag334-B124","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","article-title":"Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury","volume":"53","author":"Timmers","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B125","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","volume":"43","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B126","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300286","article-title":"Dapagliflozin in myocardial infarction without diabetes or heart failure","volume":"3","author":"James","year":"2024","journal-title":"NEJM Evid"},{"key":"2026103012565209100_ehag334-B127","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B128","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Lonborg","year":"2012","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B129","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005146","article-title":"Effects of liraglutide on reperfusion injury in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Chen","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B130","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008105","article-title":"Comparison of the effects of ticagrelor and clopidogrel on microvascular dysfunction in patients with acute coronary syndrome using invasive physiologic indices","volume":"12","author":"Park","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B131","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jacc.2017.02.034","article-title":"Ticagrelor versus clopidogrel on myocardial infarct size in patients undergoing primary percutaneous coronary intervention","volume":"69","author":"Kim","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B132","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.116.024014","article-title":"Protective effects of ticagrelor on myocardial injury after infarction","volume":"134","author":"Vilahur","year":"2016","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B133","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B134","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.118.035931","article-title":"Evaluation of microvascular injury in revascularized patients with ST-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel","volume":"139","author":"van Leeuwen","year":"2019","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.124.068938","article-title":"Effect of cangrelor on infarct size in ST-segment-elevation myocardial infarction treated by primary percutaneous coronary intervention: a randomized controlled trial (the PITRI trial)","volume":"150","author":"Bulluck","year":"2024","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B136","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","article-title":"Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (on-TIME 2): a multicentre, double-blind, randomised controlled trial","volume":"372","author":"Van't Hof","year":"2008","journal-title":"Lancet"},{"key":"2026103012565209100_ehag334-B137","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amjcard.2016.04.008","article-title":"Meta-analysis of the long-term effect of routine aspiration thrombectomy in patients undergoing primary percutaneous coronary intervention","volume":"118","author":"Mancini","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B138","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","article-title":"Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration","volume":"135","author":"Jolly","year":"2017","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B139","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0003319715585662","article-title":"Comparing direct stenting with conventional stenting in patients with acute coronary syndromes: a meta-analysis of 12 clinical trials","volume":"67","author":"Li","year":"2016","journal-title":"Angiology"},{"key":"2026103012565209100_ehag334-B140","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.jacc.2014.02.530","article-title":"A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)","volume":"63","author":"Carrick","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B141","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(16)30072-1","article-title":"Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial","volume":"387","author":"Kelbaek","year":"2016","journal-title":"Lancet"},{"key":"2026103012565209100_ehag334-B142","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.jacc.2017.03.601","article-title":"Myocardial damage in patients with deferred stenting after STEMI: a DANAMI-3-DEFER substudy","volume":"69","author":"Lonborg","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B143","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.003388","article-title":"Comparison of immediate with delayed stenting using the minimalist immediate mechanical intervention approach in acute ST-segment-elevation myocardial infarction: the MIMI study","volume":"9","author":"Belle","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B144","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004101","article-title":"INNOVATION study (impact of immediate stent implantation versus deferred stent implantation on infarct size and microvascular perfusion in patients with ST-segment-elevation myocardial infarction)","volume":"9","author":"Kim","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B145","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004838","article-title":"Deferred versus immediate stenting in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis","volume":"6","author":"Qiao","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026103012565209100_ehag334-B146","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ccd.27240","article-title":"Deferred or immediate stent implantation for primary percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"91","author":"Mahmoud","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B147","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0735-1097(01)01701-6","article-title":"A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction","volume":"39","author":"Loubeyre","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B148","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of no-reflow phenomenon in the catheterization laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B149","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1067\/mhj.2001.117778","article-title":"Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction","volume":"142","author":"Antoniucci","year":"2001","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B150","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ahj.2010.07.007","article-title":"Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction","volume":"160","author":"Zhang","year":"2010","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B151","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12872-022-02477-0","article-title":"A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study","volume":"22","author":"Ma","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2026103012565209100_ehag334-B152","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jacc.2007.10.047","article-title":"Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial","volume":"51","author":"Kelbaek","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B153","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1161\/CIRCULATIONAHA.105.545178","article-title":"Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation","volume":"112","author":"Gick","year":"2005","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B154","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","article-title":"Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts","volume":"105","author":"Baim","year":"2002","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B155","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the acute myocardial infarction STudy of ADenosine (AMISTAD) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B156","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B157","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jcin.2013.02.009","article-title":"Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (intracoronary nitroprusside versus adenosine in acute myocardial infarction)","volume":"6","author":"Niccoli","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B158","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2013.10.042","article-title":"Left ventricular remodeling and 1-year clinical follow-up of the REOPEN-AMI trial","volume":"63","author":"Niccoli","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B159","volume-title":"The REFLO-STEMI (REperfusion Facilitated by LOcal Adjunctive Therapy in ST-Elevation Myocardial Infarction) Trial: A Randomised Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside with Control for Attenuation of Microvascular Obstruction During Primary Percutaneous Coronary Intervention","author":"Nazir","year":"2016"},{"key":"2026103012565209100_ehag334-B160","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009503.pub3","article-title":"Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction","volume":"2015","author":"Su","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026103012565209100_ehag334-B162","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jcin.2015.08.033","article-title":"Limitation of infarct size and No-reflow by intracoronary adenosine Depends critically on dose and duration","volume":"8","author":"Yetgin","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B163","doi-asserted-by":"publisher","first-page":"887.e9","DOI":"10.1016\/j.ahj.2006.05.010","article-title":"Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial","volume":"152","author":"Amit","year":"2006","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B164","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/etm.2013.1139","article-title":"Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction","volume":"6","author":"Zhao","year":"2013","journal-title":"Exp Ther Med"},{"key":"2026103012565209100_ehag334-B165","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joic.12133","article-title":"Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis","volume":"27","author":"Zhao","year":"2014","journal-title":"J Interv Cardiol"},{"key":"2026103012565209100_ehag334-B166","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0735-1097(97)00277-5","article-title":"Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction","volume":"30","author":"Taniyama","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B167","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ahj.2012.06.015","article-title":"REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)","volume":"164","author":"Huang","year":"2012","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B168","doi-asserted-by":"publisher","first-page":"382086","DOI":"10.1155\/2015\/382086","article-title":"Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026103012565209100_ehag334-B169","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12872-017-0722-z","article-title":"Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis","volume":"18","author":"Niu","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026103012565209100_ehag334-B170","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011408","article-title":"Comparison of intracoronary epinephrine and adenosine for no-reflow in normotensive patients with acute coronary syndrome (COAR trial)","volume":"15","author":"Khan","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B171","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.amjcard.2024.07.011","article-title":"Efficiency and safety of intracoronary epinephrine administration in patients with ST-elevation myocardial infarction with refractory coronary no-reflow","volume":"226","author":"Ryabov","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B172","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/joic.12318","article-title":"Efficacy and safety of local intracoronary drug delivery in treatment of no-reflow phenomenon: a pilot study","volume":"29","author":"Abu Arab","year":"2016","journal-title":"J Interv Cardiol"},{"key":"2026103012565209100_ehag334-B173","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ccd.10375","article-title":"Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction","volume":"57","author":"Werner","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B174","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/01.CIR.89.6.2514","article-title":"Incidence and treatment of \u2018no-reflow\u2019 after percutaneous coronary intervention","volume":"89","author":"Piana","year":"1994","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B175","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2310\/JIM.0b013e318279b7f6","article-title":"Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon","volume":"61","author":"Ozdogru","year":"2013","journal-title":"J Investig Med"},{"key":"2026103012565209100_ehag334-B176","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.RES.68.3.847","article-title":"Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin","volume":"68","author":"Kurz","year":"1991","journal-title":"Circ Res"},{"key":"2026103012565209100_ehag334-B177","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute st-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B178","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa054374","article-title":"Intracoronary streptokinase after primary percutaneous coronary intervention","volume":"356","author":"Sezer","year":"2007","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B179","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/heartjnl-2024-324078","article-title":"Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis","volume":"110","author":"Rehan","year":"2024","journal-title":"Heart"},{"key":"2026103012565209100_ehag334-B180","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2018.19802","article-title":"Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial","volume":"321","author":"McCartney","year":"2019","journal-title":"JAMA"},{"key":"2026103012565209100_ehag334-B181","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008855","article-title":"One-year outcomes after low-dose intracoronary alteplase during primary percutaneous coronary intervention: the T-TIME randomized trial","volume":"13","author":"Maznyczka","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B182","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jacc.2020.01.041","article-title":"Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time","volume":"75","author":"McCartney","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B183","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.amjcard.2019.11.018","article-title":"Feasibility and safety of low-dose intra-coronary tenecteplase during primary percutaneous coronary intervention for ST-elevation myocardial infarction (ICE T-TIMI 49)","volume":"125","author":"Gibson","year":"2020","journal-title":"Am J Cardiol"},{"key":"2026103012565209100_ehag334-B184","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jacc.2025.10.008","article-title":"Intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for ST-segment elevation myocardial infarction and large thrombus burden: a randomized trial","volume":"87","author":"Mehta","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B185","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B186","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/jcm12062405","article-title":"The SALINE technique for the treatment of the no-reflow phenomenon during percutaneous coronary intervention in STEMI","volume":"12","author":"Grancini","year":"2023","journal-title":"J Clin Med"},{"key":"2026103012565209100_ehag334-B187","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","article-title":"Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial","volume":"36","author":"Eitel","year":"2015","journal-title":"European Heart J"},{"key":"2026103012565209100_ehag334-B188","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2014.10.031","article-title":"Remote ischemic conditioning","volume":"65","author":"Heusch","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B189","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2007.01.099","article-title":"Acute myocardial infarction with hyperoxemic therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention","volume":"50","author":"O'Neill","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B190","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCINTERVENTIONS.108.840066","article-title":"Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction","volume":"2","author":"Stone","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B191","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ccd.27905","article-title":"Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: the IC-HOT study","volume":"93","author":"David","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B192","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/ccd.29090","article-title":"One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: the IC-HOT study","volume":"97","author":"Chen","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B193","doi-asserted-by":"publisher","first-page":"107311","DOI":"10.1016\/j.ahj.2025.107311","article-title":"Effects of supersaturated oxygen therapy on infarct size and microvascular obstruction following myocardial infarction: a systematic review and meta-analysis","volume":"293","author":"Lingamsetty","year":"2026","journal-title":"Am Heart J"},{"key":"2026103012565209100_ehag334-B194","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.4244\/EIJ-D-25-00034","article-title":"Impact of intracoronary supersaturated oxygen therapy on microvascular obstruction and infarct size in patients with acute anterior myocardial infarction","volume":"21","author":"Konig","year":"2025","journal-title":"EuroIntervention"},{"key":"2026103012565209100_ehag334-B195","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/eurheartj\/ehv176","article-title":"Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trial","volume":"36","author":"Bhindi","year":"2015","journal-title":"Eur Heart J"},{"key":"2026103012565209100_ehag334-B196","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.122.012433","article-title":"Sustained mechanical aspiration thrombectomy for high thrombus burden coronary vessel occlusion: the multicenter CHEETAH study","volume":"16","author":"Mathews","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"2026103012565209100_ehag334-B197","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4244\/EIJ-D-21-00741","article-title":"A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes","volume":"18","author":"Spirito","year":"2022","journal-title":"EuroIntervention"},{"key":"2026103012565209100_ehag334-B198","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N Engl J Med"},{"key":"2026103012565209100_ehag334-B199","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment-elevation myocardial infarction","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"2026103012565209100_ehag334-B200","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1016\/j.ultrasmedbio.2016.08.013","article-title":"Sonoreperfusion therapy kinetics in whole blood using ultrasound, microbubbles and tissue plasminogen activator","volume":"42","author":"Roos","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"2026103012565209100_ehag334-B201","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/heartjnl-2015-307625","article-title":"Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size","volume":"101","author":"Wu","year":"2015","journal-title":"Heart"},{"key":"2026103012565209100_ehag334-B202","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.jacc.2016.03.542","article-title":"Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles","volume":"67","author":"Mathias","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B203","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.jacc.2019.03.006","article-title":"Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"73","author":"Mathias W","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026103012565209100_ehag334-B204","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.009536","article-title":"Sonothrombolysis improves myocardial dynamics and microvascular obstruction preventing left ventricular remodeling in patients with ST elevation myocardial infarction","volume":"13","author":"Aguiar","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103012565209100_ehag334-B205","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.echo.2024.06.019","article-title":"Sonothrombolysis before and after percutaneous coronary intervention provides the largest myocardial salvage in ST segment elevation myocardial infarction","volume":"37","author":"Jeyaprakash","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026103012565209100_ehag334-B206","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.echo.2024.06.018","article-title":"Sonothrombolysis in patients with ST-elevation myocardial infarction with electrocardiographic no-reflow after percutaneous coronary intervention: a randomized controlled trial","volume":"37","author":"El Kadi","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026103012565209100_ehag334-B207","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12471-020-01516-9","article-title":"Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol","volume":"29","author":"El Kadi","year":"2021","journal-title":"Neth Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/31\/4215\/68386759\/ehag334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/31\/4215\/68386759\/ehag334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:56:59Z","timestamp":1793379419000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/31\/4215\/8692924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":207,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2026,5,26]]},"published-print":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag334","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,14]]},"published":{"date-parts":[[2026,5,26]]}}}